281 related articles for article (PubMed ID: 31087724)
1. Quantitative vs. semiquantitative assessment of intratumoral susceptibility signals in patients with different grades of glioma.
Bhattacharjee R; Gupta RK; Patir R; Vaishya S; Ahlawat S; Singh A
J Magn Reson Imaging; 2020 Jan; 51(1):225-233. PubMed ID: 31087724
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
[TBL] [Abstract][Full Text] [Related]
3. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
Li X; Zhu Y; Kang H; Zhang Y; Liang H; Wang S; Zhang W
Cancer Imaging; 2015 Mar; 15(1):4. PubMed ID: 25889239
[TBL] [Abstract][Full Text] [Related]
4. Glioma grading using a machine-learning framework based on optimized features obtained from T
Sengupta A; Ramaniharan AK; Gupta RK; Agarwal S; Singh A
J Magn Reson Imaging; 2019 Oct; 50(4):1295-1306. PubMed ID: 30895704
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted MRI combined with susceptibility-weighted MRI: added diagnostic value for four common lateral ventricular tumors.
Yu Y; Zhang H; Xiao Z; She D; Xing Z; Yang X; Cao D
Acta Radiol; 2018 Aug; 59(8):980-987. PubMed ID: 29065704
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility-Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions.
Hsu CC; Watkins TW; Kwan GN; Haacke EM
J Neuroimaging; 2016 Jul; 26(4):383-90. PubMed ID: 27227542
[TBL] [Abstract][Full Text] [Related]
7. Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging.
Park MJ; Kim HS; Jahng GH; Ryu CW; Park SM; Kim SY
AJNR Am J Neuroradiol; 2009 Aug; 30(7):1402-8. PubMed ID: 19369602
[TBL] [Abstract][Full Text] [Related]
8. Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading.
Su CQ; Lu SS; Han QY; Zhou MD; Hong XN
Acta Radiol; 2019 Jun; 60(6):777-787. PubMed ID: 30244590
[TBL] [Abstract][Full Text] [Related]
9. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
[TBL] [Abstract][Full Text] [Related]
10. Radiomics strategy for glioma grading using texture features from multiparametric MRI.
Tian Q; Yan LF; Zhang X; Zhang X; Hu YC; Han Y; Liu ZC; Nan HY; Sun Q; Sun YZ; Yang Y; Yu Y; Zhang J; Hu B; Xiao G; Chen P; Tian S; Xu J; Wang W; Cui GB
J Magn Reson Imaging; 2018 Dec; 48(6):1518-1528. PubMed ID: 29573085
[TBL] [Abstract][Full Text] [Related]
11. Multi-parametric effect in predicting tumor histological grade by using susceptibility weighted magnetic resonance imaging in tongue squamous cell carcinoma.
Yang X; Zhu J; Dai Y; Tian Z; Yang G; Shi H; Wu Y; Tao X
BMC Med Imaging; 2019 Mar; 19(1):24. PubMed ID: 30866854
[TBL] [Abstract][Full Text] [Related]
12. Association of Glioma Grading With Inflow-Based Vascular-Space-Occupancy MRI: A Preliminary Study at 3T.
Li X; Liao S; Hua J; Guo L; Wang D; Xiao X; Zhou J; Liu X; Tan Y; Lu L; Xu Y; Wu Y
J Magn Reson Imaging; 2019 Dec; 50(6):1817-1823. PubMed ID: 30932289
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging.
Di Ieva A; Le Reste PJ; Carsin-Nicol B; Ferre JC; Cusimano MD
Neurosurgery; 2016 Dec; 79(6):839-846. PubMed ID: 27332779
[TBL] [Abstract][Full Text] [Related]
14. Contribution of susceptibility- and diffusion-weighted magnetic resonance imaging for grading gliomas.
Xu J; Xu H; Zhang W; Zheng J
Exp Ther Med; 2018 Jun; 15(6):5113-5118. PubMed ID: 29805537
[TBL] [Abstract][Full Text] [Related]
15. Assessment of tissue heterogeneity using diffusion tensor and diffusion kurtosis imaging for grading gliomas.
Raja R; Sinha N; Saini J; Mahadevan A; Rao KN; Swaminathan A
Neuroradiology; 2016 Dec; 58(12):1217-1231. PubMed ID: 27796448
[TBL] [Abstract][Full Text] [Related]
16. Combined value of susceptibility-weighted and perfusion-weighted imaging in assessing who grade for brain astrocytomas.
Wang XC; Zhang H; Tan Y; Qin JB; Wu XF; Wang L; Zhang L
J Magn Reson Imaging; 2014 Jun; 39(6):1569-74. PubMed ID: 24987755
[TBL] [Abstract][Full Text] [Related]
17. Differentiating intracranial solitary fibrous tumor/hemangiopericytoma from meningioma using diffusion-weighted imaging and susceptibility-weighted imaging.
Chen T; Jiang B; Zheng Y; She D; Zhang H; Xing Z; Cao D
Neuroradiology; 2020 Feb; 62(2):175-184. PubMed ID: 31673748
[TBL] [Abstract][Full Text] [Related]
18. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral Susceptibility Signals Reflect Biomarker Status in Gliomas.
Kong LW; Chen J; Zhao H; Yao K; Fang SY; Wang Z; Wang YY; Li SW
Sci Rep; 2019 Nov; 9(1):17080. PubMed ID: 31745161
[TBL] [Abstract][Full Text] [Related]
20. [Application of susceptibility weighted imaging in revealing intratumoral blood products and grading gliomas].
Zhang W; Zhao J; Guo D; Zhong W; Shu J; Luo Y
J Radiol; 2010 Apr; 91(4):485-90. PubMed ID: 20514004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
